| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer
1 company
Breedlove Robert Charles serves as a Principal Accounting Officer at PHAT. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $538K at current prices.
Historically, Breedlove Robert Charles's trades have earned a below-average insider score of 22/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -31.7%.
The biggest single holding is PHAT (~$538K) as Principal Accounting Officer. The recent filings there lean toward selling, a net 2,677 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Principal Accounting Officer | Sell | 524 | $13.51 | $7,079.24 | -1.1% | +0.6% | - | |
| Sep 5, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Principal Accounting Officer | Sell | 461 | $12.09 | $5,573.49 | -1.0% | +19.1% | - | |
| Jul 16, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Principal Accounting Officer | Sell | 1,692 | $8.36 | $14,151.72 | -3.4% | +50.1% | +31.7% |